Navigation Links
Needle Biopsy Works Well in Diagnosing Breast Cancer
Date:12/15/2009

It's nearly as accurate a surgical method, with fewer complications, analysis finds,,,,

TUESDAY, Dec. 15 (HealthDay News) -- When it comes to diagnosing breast cancer, women and their doctors have some options, but new research suggests that the less invasive "core needle biopsy" procedure is nearly as effective in diagnosing breast cancer as an open surgical procedure is, with fewer complications than the surgical version.

The new analysis, scheduled to published in the Jan. 5 issue of Annals of Internal Medicine, looked over data from more than 100 studies comparing different biopsy methods. It found that core needle biopsy and surgical biopsy provided women with roughly similar results.

"Our findings were that any core needle biopsy has a lower risk of complications, and was almost as accurate as surgical biopsy," said the study's principal investigator, Wendy Bruening, the associate director of the ECRI Institute Evidence-based Practice Center in Plymouth Meeting, Penn.

Additionally, Bruening said that "women diagnosed with core needle biopsy were more likely to be treated with just one surgical procedure."

The U.S. government's Agency for Healthcare Research and Quality commissioned and funded the study.

Biopsies are only done after other tests, such as a mammogram, suggest that breast cancer might be present. In any biopsy procedure, a sample is taken from the suspicious area and examined for signs of malignancy.

An "open" surgical biopsy can be done using either general or local anesthesia, explained Dr. Karen Stanford, a surgeon at the Brooklyn Hospital Center in New York City. During this procedure a scalpel is used to open the skin so that the sample can be taken. Because it's a surgical procedure, scarring is a likely complication.

Core needle biopsy, on the other hand, uses a large needle with a hollow center to draw out a "core" sample from the suspicious lesion. This procedure is done using local anesthesia, Stanford said.

The 107 studies included in Bruening's analysis examined more than 57,000 breast lesions.

Although the researchers felt that many of the studies didn't meet the standards to provide a high level of evidence, they were generally large and consistent enough to conclude that the results indicate that core needle biopsy is nearly as accurate as a surgical biopsy.

The researchers found that the rate of complications for core needle biopsy was less than 1 percent while surgical biopsy complication rates were between 2 and 10 percent.

"No biopsy method is completely accurate, but the available methods are close in accuracy," said Bruening, who added, "Women usually prefer core needle biopsy."

And, most women have the option of having core needle biopsy, said Stanford, who noted that core needle biopsy is her preferred procedure.

"Most of the time, core needle biopsy is reliable enough to gather information about the diagnosis, and it may be the only procedure that women need because most breast biopsies are negative. For that reason, if we can do a minimal procedure, it's best for patients," said Stanford.

Bruening and her colleagues recommended that women talk with their doctors about which option might be best for them.

More information

The American Cancer Society explains the different tests used to diagnose breast cancer.



SOURCES: Wendy Bruening, Ph.D., associate director, ECRI Institute Evidence-Based Practice Center, Plymouth Meeting, Pa.; Karen Stanford, M.D., surgeon, The Brooklyn Hospital Center, New York City; Jan. 5, 2010, Annals of Internal Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Advances in drug screening: building a better haystack for the needles of tomorrow
2. Microneedles enhance drug administration through skin
3. No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones
4. Revolutionary Therapy: Needle-Free Technology for the Treatment Of Blinding Eye Disease
5. Stanford Bio-X researchers use needle-thin probe to get first look at working muscle fiber
6. Special Purpose Needles Market to Reach $3.7 Billion by 2015, According to New Report by Global Industry Analysts, Inc
7. New Statistical Model Could Cut Needless Breast Biopsies
8. 11-gauge needle better than 14-gauge in breast biopsy
9. New Vertebral Biopsy Needle Features Exclusive Cutting Cannula
10. Goodbye needle, hello smoothie
11. Medical International Technology Inc. "MIT" Announces that it has received a US Patent for its Needle-Free Jet-Injector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air ... variety of colors, assortments and packaging. This staple for Valentine’s Day is a must-have, ... , For Valentine’s Day, not only are long-stem roses available, but also other ...
(Date:2/5/2016)... ... February 05, 2016 , ... The Muscular Dystrophy Association and ... launched the 14th annual “Appetite for a Cure” campaign on Feb. 1 to ... and related diseases that severely limit strength and mobility. , Now through ...
(Date:2/5/2016)... Miami, Florida (PRWEB) , ... February 05, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – is poised to once again host, Swirl, A Wine Tasting Event ...
(Date:2/5/2016)... ... ... Give To Cure today announced that it is working with ... Cure’s campaign that is crowdfunding clinical trials to help find cures faster for Alzheimer’s ... smart device. In 2015 alone, Venmo processed $7.5 billion in transactions among users. , ...
(Date:2/5/2016)... ... February 05, 2016 , ... Stuart Bentkover, MD, FACS is ... to provide the most effective tattoo removal today, Dr. Bentkover is the only doctor ... by Cynosure, the PicoSure has been approved by the Food and Drug Administration (FDA) ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... Site Profile: --> Site ... People, announced their latest primary healthcare case study where speech recognition ... and to save the practice money. Site Profile: ... Challenge: --> ,- Wirral CCG ,- VoicePower client since ... Wirral CCG ,- VoicePower client since 2013 Challenge: ...
(Date:2/5/2016)... Feb. 5, 2016 ... the "Global Obstetrics Partnering 2010-2016: Deal ... to their offering. --> http://www.researchandmarkets.com/research/hcdvg6/global_obstetrics ... "Global Obstetrics Partnering 2010-2016: Deal trends, ... their offering. --> Research and ...
(Date:2/4/2016)...  Edwards Lifesciences Corporation (NYSE: EW ), the ... and critical care monitoring, announced today that it has ... Morgan Stanley & Co. LLC to repurchase $325 million ... the Company,s previously authorized program to repurchase up to ... --> --> Under the ...
Breaking Medicine Technology: